Review
Version 1
This version is not peer-reviewed
In Vitro Self-Circularization Methods Based on Self-Splicing Ribozyme
Version 1
: Received: 5 August 2024 / Approved: 5 August 2024 / Online: 6 August 2024 (12:42:47 CEST)
How to cite: Lee, K. H.; Lee, N.-E.; Lee, S.-W. In Vitro Self-Circularization Methods Based on Self-Splicing Ribozyme. Preprints 2024, 2024080377. https://doi.org/10.20944/preprints202408.0377.v1 Lee, K. H.; Lee, N.-E.; Lee, S.-W. In Vitro Self-Circularization Methods Based on Self-Splicing Ribozyme. Preprints 2024, 2024080377. https://doi.org/10.20944/preprints202408.0377.v1
Abstract
In vitro circular RNA (circRNA) preparation methods have been gaining a lot of attention recently as several reports suggest that circRNAs are more stable with better performances in cells and in vivo than linear RNAs in various biomedical applications. Self-splicing ribozymes are considered a major in vitro circRNA generation method for biomedical applications due to their simplicity and efficiency in circularization of gene of interest. This review summarizes updates and discusses recently developed self-circularization methods based on the self-splicing ribozyme such as group I and II intron ribozymes and pros and cons of each method to prepare circRNA in vitro.
Keywords
Circular RNA; Self-circularization; Self-splicing; RNA vaccine; RNA therapeutics; Ribozyme; Group I intron; Group II intron
Subject
Medicine and Pharmacology, Medicine and Pharmacology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment